Bio Flash­back

BioSpectrum (Asia) - - Bio Contents -

In a year, bio Spec­trum cov­ers wide ar­ray of top­ics from the life-sciences sec­tor which com­prises among oth­ers biotech­nol­ogy and al­lied ar­eas, bio-pharma and pharma, health­care and med tech­nol­ogy etc.

While look­ing back it was found out that in some of the ar­ti­cles, pub­lished time to time through­out the year, some ba­sic thoughts were touched upon and lot of new in­for­ma­tion was pro­vided to the read­ers. As we en­ter 2017, this is an ef­fort to fetch the read­ers’ at­ten­tion to top 10 top­ics han­dled in depth and from var­ied an­gles by bio Spec­trum in 2016.

The Top 10 ar­ti­cles of 2016 deal with big data in health­care, lat­est sta­tus on lung can­cer burgden of Asia, china’s vi­sion on Pharma sec­tor, cro Anal­y­sis of Asian com­pa­nies, and tech­nol­ogy ad­vance­ments.

wipe health woos with wear­ables


From track­ing your sleep, calo­rie in­take to the num­ber of steps taken wear­ables are be­com­ing a cru­cial tool in life­style/ac­tiv­ity track­ing and pre­ven­tive health­care. Bio Spec­trum takes a look at the op­por­tu­ni­ties that wear­ables of­fer for the health­care sec­tor and how this tech­nol­ogy can be­come an in­dis­pens­able part of the health­care sys­tem.

help­ing health­care de­velop a cure for Big Data


If there is any­thing that doc­tors un­der­stand, it’s how to an­a­lyse data!

In fact, the en­tire pro­fes­sion is built on de­vel­op­ing an

em­pir­i­cal un­der­stand­ing of the causes of dis­eases and the ef­fi­cacy of treat­ments. And while bril­liant in­spi­ra­tion plays a key role – take the dis­cov­ery of peni­cillin for ex­am­ple – the ma­jor­ity of med­i­cal ben­e­fits come from an­a­lyz­ing and un­der­stand­ing data sets, from which life-chang­ing con­clu­sions can be drawn. But things are chang­ing.

In the past, the data might come from a sin­gle source, such as a re­search pro­gram. And even the Hu­man Genome Project, which un­locked the se­crets of our DNA, drew data from a very nar­row set of sources. To­day, the big chal­lenge that health­care pro­fes­sion­als face isn’t an­a­lyz­ing data. It’s deal­ing with so called ‘Big Data’– the sheer vol­ume of dif­fer­ent kinds of in­for­ma­tion be­ing gen­er­ated ev­ery sec­ond of the day. With the right tools, big data can be used in an unimag­in­able num­ber of ways to ad­vance sci­ence, ben­e­fit pa­tients and, last but not least, en­able health­care in­sti­tu­tions – from sin­gle surg­eries to huge hos­pi­tals – to op­er­ate as ef­fi­ciently as pos­si­ble.

lung can­cer bur­den of Asia


Lung can­cer oc­curs in two types, small cell lung can­cer and the more preva­lent non-small scale lung can­cer. Ac­cord­ing to on­col­ogy spe­cial­ists’ anal­y­sis, 85 per­cent of the lung can­cer pa­tients are di­ag­nosed with non-small scale lung can­cer. More than 50 per­cent of the world’s lung can­cer in­ci­dences oc­cur in Asia of which south east Asia is the most bur­dened re­gion. Tai­wan, South Korea, China, Sin­ga­pore and Ja­pan has the high­est num­ber of non-small scale cell lung can­cer (NSCLC) cases in the whole re­gion as al­most 20 per­cent of the can­cer deaths are reg­is­tered from these coun­tries.

China’s vi­sion of pharma & health­care sec­tor


China has en­tered into its 13th Five-Year plan for 2016 to 2020 and re­lays a strong mes­sage to re­in­force its po­ten­tials within the health­care sec­tor. China has em­pha­sized on chang­ing the model from re­search and de­vel­op­ment to in­no­va­tion with fo­cus on mak­ing break­throughs in bi­o­log­ics medicine and to fa­cil­i­tate bet­ter pro­tec­tion of in­tel­lec­tual prop­erty rights. In 13th five-year plan, China in­tends to de­velop and adopt cy­ber-medicine and op­ti­mized dis­tri­bu­tion of re­sources to im­prove the qual­ity of ba­sic health ser­vices.

The Fat fight­ers


Meet the Ro­botic Sur­geons who con­ducted nearly 4,000 pro­ce­dures in 30 hos­pi­tals spread across the coun­try dur­ing 2015 to help cut flab. Ear­lier doc­tors were us­ing la­paro­scopic tech­niques to per­form gas­tric by­pass surgery. To­day, ro­botic surgery is the more pre­ferred method. Sim­i­larly, in Tech­nol­ogy Ad­vance­ments: Dig­i­tal Pathol­ogy Bio Spec­trum takes a look at how com­put­ing tech­nol­ogy is rev­o­lu­tion­iz­ing pathol­ogy and some of the prod­ucts avail­able in the mar­ket.

global busi­ness ser­vices a new way for­ward for life sciences com­pa­nies


Now, com­pa­nies – par­tic­u­larly those with op­er­a­tions in many dif­fer­ent ju­ris­dic­tions – are adopt­ing a more holis­tic ap­proach in how they de­liver ser­vices like IT, fi­nance, ac­count­ing, hu­man re­sources, pro­cure­ment and other busi­ness ser­vices across an or­gan­i­sa­tion. As in­ter­na­tional life sciences com­pa­nies seek ways to trans­form their op­er­a­tions in the midst of wrench­ing change, they are es­tab­lish­ing global busi­ness ser­vices (GBS), which is a cross-func­tional, globe-span­ning model that in­te­grates re­sources, ca­pa­bil­i­ties and sys­tems through­out the en­tire en­ter­prise.

Calorime­try: highly ef­fec­tive Tool for Com­bat­ing An­tibi­otic re­sis­tance


The prob­lem of multi-re­sis­tant bac­te­ria is in­creas­ing and the health­care costs and im­pli­ca­tions are now a se­ri­ous global con­cern that needs ad­dress­ing. Con­se­quently, the search is on for novel and ef­fec­tive so­lu­tions.

CRO In­dus­try Anal­y­sis


Clin­i­cal re­search or­ga­ni­za­tions (CROs) in Asia Pa­cific have wit­nessed growth in al­liances, ac­qui­si­tions, and joint ven­tures due to ex­pan­sion strate­gies of global com­pa­nies and in­creased out­sourc­ing of re­search ac­tiv­i­ties by the phar­ma­ceu­ti­cal com­pa­nies. Drug com­pa­nies are re­al­iz­ing that dis­eases in Asia have their own har­ac­ter­is­tics and one size fits all’ can­not ap­plied, which means, com­pa­nies are do­ing clin­i­cal trial on Asian pop­u­la­tion to de­velop a drug spe­cific for the re­gion. Bio Spec­trum Asia takes a look at re­cent trends, in­no­va­tions and tech­nolo­gies gain­ing mo­men­tum in clin­i­cal re­search space.

In­no­va­tions that re­de­fine health­care


Tech­nol­ogy has brought a rev­o­lu­tion that has re­de­fined the en­tire health­care in­dus­try be it con­nect­ing to the pa­tients, real time mon­i­tor­ing, gene edit­ing, drug dis­cov­ery break­throughs, DNA map­ping and so on. Break­through tech­nolo­gies bud­ding in the labs are game chang­ers of fu­ture.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.